Clinical Policy Review: Spinal Injections

Date posted: 22nd February 2018 Clinical Policy Review: Spinal Injections thumbnail image

Have your say

As part of the ongoing review of clinical policies for all the Clinical Commissioning Groups (CCGs) in Lancashire and South Cumbria, we are now seeking feedback on the policy for the management of back pain – spinal injections.

We are seeking views and comments from patients, the public and other stakeholders. This consultation is for a period of 6 weeks.

The proposed policy can be found below. For some CCGs this is a new policy while for others this is a revised and updated policy. You are invited to read the draft clinical policy before giving your feedback. You can click on the link next to the policy in order to complete a survey and give your views.

To help you there is also a Level of Change document that identifies the main elements of change in the updated policy compared to the current policy for your CCG. The changes to current policy differ across CCG areas.

There is also a Frequently Asked Questions document that may answer any queries you have about the process or about the proposed policy.

Your comments will be fed back as part of the development process.

Comments on this policy should be submitted by Friday 6 April 2018.

If you would prefer to have a hard-copy of the policy and/or of the survey questionnaire please email or call 01772 214244.

Proposed Policy for the Management of Back Pain – Spinal Injections

Read the policy here

View the levels of change here

Feedback via the survey here

If you have any further questions about this policy or the process being undertaken email

If you require any of these documents in an alternative format such as Braille, larger print, audio, British Sign Language or in a language other than English please contact the Customer Care Team in one of the following ways:

Freephone: 0800 032 2424 Telephone: 01772 777 952 Textphone: 01772 227 005 Email:

Further opportunities will be made available for your involvement and feedback on other clinical policies as and when they are developed and available for discussion.

Accessibility tools

Return to header